¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"residual spray"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • residual cyst
    ÀÜ·ù³¶
  • residual free chlorine
    ÀÜ·ùÀ¯¸®¿°¼Ò
  • residual hearing
    ÀÜû
  • residual immunity
    ÀÜ¿©¸é¿ª
  • residual latency
    ÀÜ·ùÀẹ, ÀÜ·ùÀá½Ã
  • residual lumen
    ÀÜ·ù¼Ó°ø°£, ÀÜ·ù³»°­
  • residual nitrogen
    ÀÜ¿©Áú¼Ò
  • residual nucleus
    ÀÜ·ùÇÙ
  • residual paralysis
    ÈÄÀ¯¸¶ºñ
  • residual period
    ÀÜ·ù±â°£
  • residual proteinuria
    ÀÜ·ù´Ü¹é´¢
  • residual quotient
    ÀÜ·ùÁö¼ö, ÀܱâÀ²
  • residual radiation
    ÀÜ·ù¹æ»ç¼±
  • residual radioactivity
    ÀÜ·ù¹æ»ç´É
  • residual ray
    ÀÜ·ù¼±
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • coherent residual transverse magnetization
    °áÁýÀÜ·ù°¡·ÎÃàÀÚ±âÈ­
  • functional residual capacity
    ±â´ÉÀûÀܱâ¿ë·®
  • residual carbon
    ÀÜ¿©Åº¼Ò
  • residual chlorine
    ÀÜ·ù¿°¼Ò
  • residual chromatin
    ÀÜ¿©¿°»öÁú
  • residual current
    ÀÜ·ùÀü·ù
  • residual cyst
    ÀÜ·ù³¶
  • residual free chlorine
    À¯¸®ÀÜ·ù¿°¼Ò
  • residual delirium
    ÀÜ·ù¼¶¸Á
  • residual hearing
    ÀÜû
  • residual immunity
    ÀÜ¿©¸é¿ª
  • residual latency
    ÀÜ·ùÀẹ
  • residual lumen
    ÀÜ¿©³»°­
  • residual transverse magnetization
    ÀÜ¿©È¾ÀÚ±âÈ­
  • residual volatile matter
    ÀÜ·ùÈֹ߼ººÐ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • functional residual capacity =FRC
    ±â´ÉÀû ÀÜ·ù¿ë·®(íÑ×¶éÄÕá), ±â´ÉÀû Àܱⷮ(íÑѨÕá).
  • hearing, residual
    ÀÜû
  • incoherent residual transverse magnetization
    ºñ°áÁý ÀÜ·ù Ⱦ´Ü ÀÚ±âÈ­
  • rate of residual expansion
    ÀÜÁ¸ÆØÃ¢·ü(íÑðíø³óìëÒ).
  • residual
    ÀÜ·ù.
  • residual abscess
    Àç¹ß³ó¾ç(î¢Û¡ÒÛåË)
  • residual accommodation
    ÀÜ¿©Á¶Àý
  • residual air
    Àܱâ(íÑѨ).
  • residual albuminuria
    ÀÜÁ¸´Ü¹é´¢(íÑðíÓ±ÛÜèñ).
  • residual antigen
    ÀÜ¿©Ç׿ø(íÑæ®ù÷ê«).
  • residual antigen
    ÀÜ·ùÇ׿ø, ÀÜÁ¸Ç׿ø
  • residual antigen
    ÀÜ¿©Ç׿ø(íÑæ®ù÷ê«).
  • residual astigmatism
    ÀÜ¿©³­½Ã
  • residual body
    ÀÜ·ùü(íÑ׺ô÷), ÀÜÁ¸Ã¼(íÑðíô÷)
  • residual body
    ÀÜ¿©¼Òü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FRV full-length retroviral [sequence]; functional residual volume
MRD maximum rate of depolarization; measles-rindenpest-distemper [virus group]; medical records departme...
PFRC predicted functional residual capacity
PImax maximum inspiratory pressure at residual volume
PRBC packed red blood cells; placental residual blood volume
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
RVF Residual Volume Fraction
ROFA Residual oil fly ash
RRF Residual renal function
PVR post void residual
PVR post-void residual urine volume
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • residual cyst
    ÀÜ·ù ³¶, ÀÜ·ù¼º ³­Á¾
    1. ´ë°³ Ä¡±Ù´Ü ³¶Á¾À¸·Î ÇØ´ç Ä¡¾ÆÀÇ ¹ßÄ¡ ÈÄ¿¡µµ ±× ÀÚ¸®¿¡ ³²¾Æ¼­ ¹ß»ýÇÑ´Ù. ¹æ»ç¼± »çÁø»ó º´¼Ò´Â °æ°è°¡ ¸íÈ®ÇÑ ±ÕÁúÇÑ ´Ü¹æ¼º ¾Ï¿°À» ³ªÅ¸³½´Ù. 2. ´ë°³ Ä¡±Ù´Ü ³¶Á¾À¸·Î ÇØ´ç Ä¡¾ÆÀÇ ¹ß°Å ÈÄ¿¡µµ ±× À§Ä¡¿¡ ³²¾Æ¼­ ¹ß»ýÇÑ´Ù. ÀÜ·ù¼º, Ãø¹æ Ä¡ÁÖ¼º ¹× ÇÔÄ¡¼º ³¶Á¾ µîÀº »óÈ£ ºñ½ÁÇÏ¿© °¨º°ÀÌ Èûµé ¶§°¡ Àֱ⠶§¹®¿¡ ¹ßÄ¡Àü ¹æ»ç¼± »çÁøÀ» Âü°íÇØ¾ß ÇÏ¸ç ¾Ç°ñÀÇ ¹«Ä¡¾Ç ºÎÀ§¿¡ ¹ß»ýÇÏ´Â ¿ø½Ã¼º ³¶Á¾µµ ¼úÀü ±â·Ï°ú º´·ÂÀ¸·Î °¨º°ÇÑ´Ù. ¹æ»ç¼± »çÁø»ó, º´¼Ò´Â °æ°è°¡ ¸íÈ®ÇÑ ±ÕÁúÇÑ ´Ü¹æ¼º ¾Ï¿µÀ» ³ªÅ¸³½´Ù. ¿Í°úÀû ÀýÃâ°ú ¼ÒÆÄ¼ú·Î Ä¡·áÇÑ´Ù.
  • residual dental caries
    ÀÜÁ¸ Ä¡¾Æ¿ì½ÄÁõ
    ÀÜÁ¸ Ä¡¾Æ ¿ì½Ä »ó¾ÆÁú. ¿ì½ÄÀÌ µÈ ¹°ÁúÀÌ »èÁ¦µÈ ¿Íµ¿¿¡ ³²¾Æ ÀÖ°í ±× À§¿¡ ÃæÀü¹°ÀÌ À§Ä¡ÇÑ °Í.
  • residual mercury
    ÀÜ¿© ¼öÀº
  • residual pulp
    Àܼö
  • residual ridge crest
    ÀÜÁ¸ Ä¡Á¶´É
  • residual root
    ÀܱÙ
  • residual shrinkage
    ÀÜ·ù À§Ãà
  • residual stress
    ÀÜ·ù ÀÀ·Â, ÀÜ¿© ÀÀ·Â
    Àη¹ÀÌ ³³Çü Á¦ÀÛ ½Ã ³³ °¡¿­ÀÌ ºÎÁ·ÇϹǷΠÀÎÇØ Àη¹ÀÌ ¿Íµ¿¿¡ ¾ïÁö·Î ¾ÐÀÔÇÏ°Ô µÇ´Âµ¥ À̶§ ¾Ð·ÂÀ» ¸¹ÀÌ ¹ÞÀº ºÎºÐ¿¡ Àû°Ô ¹ÞÀº ºÎºÐº¸´Ù ÀÜÀ¯ ÀÀ·ÂÀÌ Á¸ÀçÇÔÀ¸·Î¼­ ³³ÇüÀÇ º¯ÇüÀ» ÃÊ·¡ÇÒ ¼ö°¡ ÀÖ´Ù.
  • residual urine
    ÀÜ´¢
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
residual lumen The remnants of the pituitary diverticulum that occur between the pars distalis and pars intermedia; a distinct lumen is present in some animals, but, in humans, is present only during prenatal development and sometimes in young children.
Synonym: residual lumen.
(05 Mar 2000)
residual ovary syndrome <syndrome> The development of a pelvic mass, pelvic pain, and occasionally dyspareunia following hysterectomy without removal of both ovaries.
(05 Mar 2000)
residual ridge That portion of the processus alveolaris remaining in the edentulous mouth following resorption of the section containing the alveoli.
(05 Mar 2000)
residual schizophrenia Blunted or inappropriate affect, social withdrawal, eccentric behaviour, or loose associations, but without prominent psychotic symptoms, as the remains of former psychotic symptoms of schizophrenia.
(05 Mar 2000)
residual urine Urine remaining in the bladder at the end of micturition in cases of prostatic obstruction, bladder atony, etc.
(05 Mar 2000)
residual volume The volume of air remaining in the lungs at the end of a maximal expiration. Common abbreviation is rv.
(12 Dec 1998)
neoplasm, residual Remnant of a tumour or cancer after primary, potentially curative therapy. (dr. Daniel masys, written communication)
(12 Dec 1998)
functional residual air The volume of air remaining in the lungs at the end of a normal, quiet expiration. It is the sum of the residual volume and the expiratory reserve volume. Common abbreviation is frc.
(12 Dec 1998)
functional residual capacity The volume of air remaining in the lungs at the end of a normal, quiet expiration. It is the sum of the residual volume and the expiratory reserve volume. Common abbreviation is frc.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • residual radiation
    ÀÜ·ù¹æ»ç¼±
  • residual ray
    ÀÜ·ù¼±
  • residual security
    ÀÜ¿© Áõ±Ç(º¸Åë ÁÖ³ª Àüȯ »çä)
  • residual sovereignty
    ÀáÀç ÁÖ±Ç
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á